Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 9556 | 2021 |
Mitochondrial complex I deficiency in Parkinson's disease AHV Schapira, JM Cooper, D Dexter, JB Clark, P Jenner, CD Marsden Journal of neurochemistry 54 (3), 823-827, 1990 | 2462 | 1990 |
2.2 Mb of contiguous nucleotide sequence from chromosome III of C. elegans R Wilson, R Ainscough, K Anderson, C Baynes, M Berks, J Bonfield, ... Nature 368 (6466), 32-38, 1994 | 1836 | 1994 |
Mitochondrial complex I deficiency in Parkinson's disease AHV Schapira, JM Cooper, D Dexter, P Jenner, JB Clark, CD Marsden The Lancet 333 (8649), 1269, 1989 | 1696 | 1989 |
Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxide: implications for neurodegenerative diseases MWJ Cleeter, JM Cooper, VM Darley-Usmar, S Moncada, AHV Schapira FEBS letters 345 (1), 50-54, 1994 | 1529 | 1994 |
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial RECOVERY Collaborative Group Lancet (London, England) 397 (10285), 1637, 2021 | 1371 | 2021 |
Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy ME Gegg, JM Cooper, KY Chau, M Rojo, AHV Schapira, JW Taanman Human molecular genetics 19 (24), 4861-4870, 2010 | 967 | 2010 |
Mitochondrial defect in Huntington's disease caudate nucleus M Gu, MT Gash, VM Mann, F Javoy‐Agid, JM Cooper, AHV Schapira Annals of Neurology: Official Journal of the American Neurological …, 1996 | 861 | 1996 |
Anatomic and Disease Specificity of NADH CoQ1 Reductase (Complex I) Deficiency in Parkinson's Disease AHV Schapira, VM Mann, JM Cooper, D Dexter, SE Daniel, P Jenner, ... Journal of neurochemistry 55 (6), 2142-2145, 1990 | 853 | 1990 |
Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission L Alvarez-Erviti, Y Seow, AH Schapira, C Gardiner, IL Sargent, MJA Wood, ... Neurobiology of disease 42 (3), 360-367, 2011 | 744 | 2011 |
A review of the immobilization of enzymes in electropolymerized films PN Bartlett, JM Cooper Journal of Electroanalytical Chemistry 362 (1-2), 1-12, 1993 | 646 | 1993 |
Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body P Ashton, RA Patchell, J Cooper, BA Young US Patent 5,836,935, 1998 | 596 | 1998 |
Chaperone-mediated autophagy markers in Parkinson disease brains L Alvarez-Erviti, MC Rodriguez-Oroz, JM Cooper, C Caballero, I Ferrer, ... Archives of neurology 67 (12), 1464-1472, 2010 | 583 | 2010 |
Biochemical abnormalities and excitotoxicity in Huntington's disease brain SJ Tabrizi, MWJ Cleeter, J Xuereb, JW Taanman, JM Cooper, ... Annals of Neurology: Official Journal of the American Neurological …, 1999 | 533 | 1999 |
A novel α-synuclein missense mutation in Parkinson disease C Proukakis, CG Dudzik, T Brier, DS MacKay, JM Cooper, GL Millhauser, ... Neurology 80 (11), 1062-1064, 2013 | 528 | 2013 |
Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains ME Gegg, D Burke, SJR Heales, JM Cooper, J Hardy, NW Wood, ... Annals of neurology 72 (3), 455-463, 2012 | 521 | 2012 |
Biosensors: practical approach AEG Cass Oxford: Oxford University,, 1990 | 493* | 1990 |
Irreversible inhibition of mitochondrial complex I by 1‐methyl‐4‐phenylpyridinium: evidence for free radical involvement MWJ Cleeter, JM Cooper, AHV Schapira Journal of neurochemistry 58 (2), 786-789, 1992 | 479 | 1992 |
Complex I inhibitors induce dose‐dependent apoptosis in PC12 cells: relevance to Parkinson's disease A Hartley, JM Stone, C Heron, JM Cooper, AHV Schapira Journal of neurochemistry 63 (5), 1987-1990, 1994 | 459 | 1994 |
Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease VM Mann, JM Cooper, D Krige, SE Daniel, AHV Schapira, CD Marsden Brain 115 (2), 333-342, 1992 | 444 | 1992 |